Sun Pharma records growth of 13.1 percent over Q2 last year. The gross sales reached at Rs. 108,092 million. In this quarter, the company launched 34 new products in the Indian market.
Sun Pharma market share has increased by 0.5 pc to 8.6 pc over the last one year, as per AIOCD AWACS MAT Sept-2022 report. As per SMSRC MAT August-2022 report, Sun Pharma is topped in prescriptions with 12 different doctor categories.
- Read more about Sun Pharma shows 13 percent growth for Q2
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/sun-pharma-shows-13-percent-growth-for-q2
No comments:
Post a Comment